Akanda Corp (AKAN)
1.17
+0.06
(+5.41%)
USD |
NASDAQ |
Sep 27, 16:00
1.16
-0.01
(-0.85%)
After-Hours: 20:00
Akanda Total Assets (Quarterly): 8.84M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.84M |
| June 30, 2023 | 36.51M |
| December 31, 2022 | 39.00M |
| June 30, 2022 | 43.48M |
| Date | Value |
|---|---|
| December 31, 2021 | 8.046M |
| September 30, 2021 | 25.49M |
| December 31, 2020 | 4.275M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
4.275M
Minimum
Dec 2020
43.48M
Maximum
Jun 2022
23.66M
Average
25.49M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 321.70M |
| Biodexa Pharmaceuticals PLC | 17.67M |
| Verona Pharma PLC | 434.12M |
| NuCana PLC | 25.38M |
| Autolus Therapeutics PLC | 853.62M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.67M |
| Shareholders Equity (Quarterly) | -3.829M |
| Debt to Equity Ratio | -1.009 |
| Current Ratio | 0.1775 |
| Net Debt Paydown Yield | -0.41% |